an experimental experience

8/4/23 at 12:28pm

Organization

Author

Phalguni Deswal

39 words

Comments

Hipra’s Bimervax targets the alpha and beta viral variants, but the EMA recently said it seeks vaccines designed against XBB 1.5 Omicron.

You are the first to view

http://www.pharmaceutical-technology.com/news/accord-commercialise-hipra-covid-19-vaccine-uk/

Create an account or login to join the discussion